Emergent BioSolutions (EBS) PT Lowered to $23 at Cantor Fitzgerald
Tweet
Share
E-mailGet Alerts EBS Hot Sheet
Price: $4.50 --0%
Rating Summary:
12 Buy, 5 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 5 | Down: 8 | New: 18
Rating Summary:
12 Buy, 5 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 5 | Down: 8 | New: 18
Join SI Premium – FREE
Cantor Fitzgerald analyst Brandon Folkes lowered the price target on Emergent BioSolutions (NYSE: EBS) to $23.00 (from $33.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Nomura/Instinet Downgrades China Literature (772:HK) (CHLLF) to Neutral
- IPCA Laboratories (IPCA:IN) PT Raised to INR2,060 at Nomura/Instinet
- Teijin Ltd (3401:JP) PT Raised to JPY1,860 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
